Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Thousands More Medtech Jobs At Risk If Tax Restarts, Think Tank Says

Executive Summary

The center-right American Action Forum says whether the US Congress elects to permanently repeal the device excise take or let tax collection restart in 2018 will have stark implications for medtech jobs.


Related Content

Device-Tax Repeal Opportunity Slips Away As GOP Pulls Health Bill From Consideration
Device-Tax Repeal In Doubt As House Postpones Health Bill Vote
AdvaMed Pushes For Trump To Address Device Tax In Joint-Session Address





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst